# Phase 3 pain trials recruiting: 78 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 78 trials in phase 3 for pain that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 pain trials: 78 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/pain

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 78
- Recruiting or not yet: 78
- Read on: November 19, 2026

## Trials

The 25 newest of 78, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07930559 | Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue Contusions | Aponia Laboratories, Inc. | Phase 3 | Recruiting | Acute Pain Due to Trauma | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930559) |
| October 19, 2026 | NCT07880743 | Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Pain, Postoperative | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880743) |
| October 19, 2026 | NCT07880392 | Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Not yet recruiting | Acute Pain | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880392) |
| October 16, 2026 | NCT07878156 | Dexmedetomidine Use for Greater Occipital Nerve Block in Pediatric Posterior Fossa Tumor Surgery. | Children's Cancer Hospital Egypt 57357 | Phase 3 | Recruiting | Posterior Fossa Tumor | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878156) |
| October 13, 2026 | NCT07871266 | Effect of Nebulized Lignocaine on Emergence Agitation After Sevoflurane Anesthesia in Pediatric Patients Undergoing Tonsillectomy | Assiut University | Phase 3 | Not yet recruiting | Emergence Agitation, Emergence Delirium, Postoperative Pain | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871266) |
| October 9, 2026 | NCT07869173 | "Evaluation of the Efficacy of Intravenous Lidocaine on Chronic Post-operative Pain in Patients Requiring Emergency Abdominal Surgery. A... | Nantes University Hospital | Phase 3 | Not yet recruiting | Chronic Pain | 266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869173) |
| October 8, 2026 | NCT07864896 | Suzetrigine in TKA | Hospital for Special Surgery, New York | Phase 3 | Recruiting | Total Knee Arthroplasty (TKA), Total Knee Arthroplasty \\(TKA\\), Total Knee Replacement, Total Knee Replacement Surgery... | 148 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864896) |
| October 5, 2026 | NCT07857733 | Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1 | Ambros Therapeutics, Inc. | Phase 3 | Recruiting | Complex Regional Pain Syndrome Type I | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857733) |
| September 29, 2026 | NCT07847047 | Safety and Efficacy of Dexamethasone Versus Dexmedetomidine as Adjuvants in PENG Block in Hip Surgeries for Postoperative Pain Management | Assiut University | Phase 3 | Not yet recruiting | Postoperative Pain, Total Hip Arthroplasty (THA) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847047) |
| September 28, 2026 | NCT07845071 | An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin | Adneuris Therapeutics, Inc. | Phase 3 | Recruiting | Pain | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845071) |
| September 24, 2026 | NCT07839715 | Suzetrigine Post DIEP | Vanderbilt University Medical Center | Phase 3 | Not yet recruiting | Post-operative Pain, DIEP Flap Breast Reconstruction, DIEP Flap, Opioid, Suzetrigine, ERAS | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839715) |
| September 24, 2026 | NCT07838506 | Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic... | Okyo Pharma Ltd | Phase 3 | Not yet recruiting | Neuropathic Corneal Pain | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838506) |
| September 11, 2026 | NCT07816302 | Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department | Tehran University of Medical Sciences | Phase 3 | Not yet recruiting | Pain, Ketorolac, Intranasal Drug Administration | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816302) |
| August 13, 2026 | NCT07761936 | Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations | Universita di Verona | Phase 3 | Recruiting | PARKINSON DISEASE (Disorder), Pain, Pain Management, Parkinson Disease (PD) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761936) |
| July 29, 2026 | NCT07734740 | Perioperative Haemostasis, Procedure-Related Pain After Physiological or Pharmacological Modifications of Local Anaesthesia Around the Eyes | Prince of Wales Hospital, Shatin, Hong Kong | Phase 3 | Not yet recruiting | Dermatochalasis of Upper Eyelid, Blepharoplasty | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734740) |
| July 29, 2026 | NCT07733193 | Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases. | Centre Henri Becquerel | Phase 3 | Not yet recruiting | Bone Metastases | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733193) |
| July 6, 2026 | NCT07682558 | Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management | University Hospital, Basel, Switzerland | Phase 3 | Not yet recruiting | Cancer Pain, Cancer Palliative Care | 318 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682558) |
| June 24, 2026 | NCT07665762 | Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in... | The University of Hong Kong | Phase 3 | Recruiting | Pain, Postoperative, Liposomal Bupivacaine, Dexamethasone, Supraclavicular Brachial Plexus Block, High Risk Factors... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665762) |
| May 4, 2026 | NCT07565870 | Methadone for Enhanced Postoperative Analgesia in Intermediate-Risk Noncardiac Surgery (MELODY) | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Postoperative Pain, Recovery | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565870) |
| April 23, 2026 | NCT07548385 | Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN | Icahn School of Medicine at Mount Sinai | Phase 3 | Recruiting | Total Knee Replacement Surgery, Post-operative Pain | 235 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07548385) |
| April 20, 2026 | NCT07539623 | Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery | Icahn School of Medicine at Mount Sinai | Phase 3 | Recruiting | Bariatric Surgery, Cardiac Surgery With Sternotomy, Post-operative Pain | 235 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539623) |
| March 30, 2026 | NCT07502235 | The Effect of Lactoferrin on Pain Management Following Cesarean Section | Ain Shams University | Phase 3 | Not yet recruiting | Cesarean Birth, Post Operative Analgesia | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502235) |
| March 24, 2026 | NCT07490496 | Phase 3 Bunionectomy Study | Cali Pharmaceuticals LLC | Phase 3 | Not yet recruiting | Postoperative Pain, Bunion | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07490496) |
| March 4, 2026 | NCT07450430 | Optimal Timing of Ketamine Initiation for SCD Pain | Boston Children's Hospital | Phase 3 | Not yet recruiting | Sickle Cell Disease, Sickle Cell Crisis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07450430) |
| March 4, 2026 | NCT07448285 | Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia | Biobizkaia Health Research Institute | Phase 3 | Recruiting | Chronic Pain | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448285) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Hospital for Special Surgery, New York | 3 |
| Ambros Therapeutics, Inc. | 2 |
| AFT Pharmaceuticals, Ltd. | 2 |
| University Hospital, Brest | 2 |
| The University of Hong Kong | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| University of Utah | 2 |
| University Hospital, Strasbourg, France | 2 |
| Tehran University of Medical Sciences | 2 |
| Medical University of South Carolina | 2 |
| Assiut University | 2 |
| University Health Network, Toronto | 2 |
| Rutgers, The State University of New Jersey | 2 |
| [Ache Laboratorios Farmaceuticos S.A.](https://specstream.ai/data/clinical-trials/company/ache-laboratorios-farmaceuticos-s-a) | 1 |
| Centre Henri Becquerel | 1 |
| Ensysce Biosciences | 1 |
| Ain Shams University | 1 |
| Cali Pharmaceuticals LLC | 1 |
| Oman Ministry of Health | 1 |
| University of California, San Francisco | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Boston Children's Hospital | 1 |
| Pirogov Russian National Research Medical University | 1 |
| St. Louis University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 31 |
| France | 13 |
| Hong Kong | 4 |
| Canada | 4 |
| Egypt | 2 |
| Russia | 2 |
| United Kingdom | 2 |
| Spain | 2 |
| China | 2 |
| Oman | 1 |
| Israel | 1 |
| Germany | 1 |
| Hungary | 1 |
| Australia | 1 |
| New Zealand | 1 |
| Denmark | 1 |
| Italy | 1 |
| Switzerland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Georgian restaurants in the United States](https://specstream.ai/data/businesses/georgian-restaurants/united-states)
- [German restaurants in the United States](https://specstream.ai/data/businesses/german-restaurants/united-states)
- [Glass companies in the United States](https://specstream.ai/data/businesses/glass-companies/united-states)
- [Gluten free restaurants in the United States](https://specstream.ai/data/businesses/gluten-free-restaurants/united-states)
- [Graphic design firms in the United States](https://specstream.ai/data/businesses/graphic-design-firms/united-states)
- [Grout companies in the United States](https://specstream.ai/data/businesses/grout-companies/united-states)
